ClinicalTrials.govpublic full text
Ziftomenib Maintenance Post Allo-HCT
acute myeloid leukemia, acute myeloid leukemia in remission, npm1 mutation, kmt2a rearrangement, allogeneic hematopoietic cell transplantation (hct), allo-hct, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 966076
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.